Clinical Trial Update: Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT [Phase 1]

View source ↗

Summary

Phase 1 safety trial evaluating donor natural killer cell donor lymphocyte infusion after nonmyeloablative autologous stem cell transplant in lymphoma; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• NK cell donor lymphocyte infusion (natural killer cell donor lymphocyte infusion)

Snippet

Sponsor: David Rizzieri, MD | Conditions: Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2014-03-27